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Gastrointestinal involvement affects 30–40% of the patients with chronic Chagas disease.
Esophageal symptoms appear once the structural damage is established. Little is known
about the usefulness of high resolution manometry to early identification of esophageal
involvement.
Method
We performed a cross-sectional study at the Vall d’Hebron University Hospital (Barcelona,
Spain) between May 2011 and April 2012. Consecutive patients diagnosed with Chagas
disease in the chronic phase were offered to participate. All patients underwent a structured
questionnaire about digestive symptoms, a barium esophagogram (Rezende classification)
and an esophageal high resolution manometry (HRM). A control group of patients with
heartburn who underwent an esophageal HRM in our hospital was selected.
Results
62 out of 73 patients that were included in the study fulfilled the study protocol. The median
age of the Chagas disease group (CG) was 37 (IQR 32–45) years, and 42 (67.7%) patients
were female. Twenty-seven (43.5%) patients had esophageal symptoms, heartburn being
the most frequent. Esophagogram was abnormal in 5 (8.77%). The esophageal HRM in the
CG showed a pathological motility pattern in 14 patients (22.6%). All of them had minor dis-
orders of the peristalsis (13 with ineffective esophageal motility and 1 with fragmented peri-
stalsis). Hypotonic lower esophageal sphincter was found more frequently in the CG than in
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the control group (21% vs 3.3%; p<0.01). Upper esophageal sphincter was hypertonic in 22
(35.5%) and hypotonic in 1 patient. When comparing specific manometric parameters or
patterns in the CG according to the presence of symptoms or esophagogram no statistically
significant association were seen, except for distal latency.
Conclusion
The esophageal involvement measured by HRM in patients with chronic Chagas disease in
our cohort is 22.6%. All the patients with esophageal alterations had minor disorders of the
peristalsis. Symptoms and esophagogram results did not correlate with the HRM results.
Author Summary
Chagas disease is a parasitic disease mainly transmitted to humans by blood-sucking insects.
The disease was endemic in Latin America, but it is now a global disease due to migratory
movements. The disease can affect the heart and the digestive system (mainly esophagus
and colon). Classically, esophageal assessment in Chagas disease is performed by X-ray and
self-reported symptoms. However, they lack accuracy and detect only advanced stage of the
disease. Recently, new tools, such as esophageal high resolution manometry, provide more
detailed information about the motility disorders of the esophagus. We assessed the esoph-
ageal involvement in patients with Chagas disease by means of high resolution manometry
and compared the findings with the X-ray and self-reported symptoms. We found a low rate
of mild severity motility disorders. We did not find an association between X-ray assessment
and symptoms with the high resolution manometry findings. The assessment of esophageal
involvement in patients with Chagas disease may benefit from early diagnosis by high reso-
lution manometry, although more research is needed.
Introduction
Chagas disease (CD) is caused by the hemoflagellate protozoan, Trypanosoma cruzi. CD is
endemic in Latin America. However migratory flows have spread the disease all over the world;
the non-endemic countries with more cases are The United States of America and Spain.[1] Its
prevalence worldwide is around 10 million cases and 25 million people remain at risk.[2]
Patients with the chronic form of CD usually remain asymptomatic for years. Decades after
the infection around 30–40% of the patients will develop visceral involvement caused by direct
lesion, inflammation and fibrosis of the affected organs. The disease affects mainly the heart
and the gastrointestinal tract, leading in some cases to dilated cardiomyopathy, megacolon and
megaesophagus. [3]
Gastrointestinal involvement ranges between 5–35% of patients, showing lower frequencies
in studies from non-endemic countries, despite being similar populations.[3,4] Dilatation of
the digestive tract and motor disorders, such as achalasia, delayed gastric emptying and altered
colonic transit, are found in affected patients.[5] The pathogenesis behind the digestive
involvement lays on enteric nervous system injury.[6]
Dysphagia is usually the first symptom of esophageal involvement in CD, and achalasia and
dilatation of the esophagus the main findings.[7] Contrary to what is seen in idiopathic achala-
sia, the pressure in the lower esophageal sphincter (LES) in patients with CD is diminished,[8]
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reflecting an impairment in both excitatory and inhibitory innervations. Unfortunately, the
treatment for esophageal involvement in CD is addressed to symptoms relief.
Classically, esophageal assessment in CD is performed with barium swallow. Conventional
manometry has also been used in research studies. Recently, new tools that provide a greater
knowledge about the esophageal involvement such as high resolution manometry (HRM) are
available; however data of their use in CD are still scant.
The objective of this study is to describe the findings of the esophageal HRM in patients




Consecutive CD patients attending the Tropical Medicine Unit of the Vall d’Hebron University
Hospital (Barcelona, Spain) between May 2011 and April 2012 were invited to participate.
Patients were referred to our units from blood donors centers, primary care centers, mother-
to-child transmission prevention program and emergency service or hospitalization. Some
patients came directly to other unit for a voluntary screening.
Inclusion criteria included a minimum age of 18 years old and confirmed diagnosis of CD
in the chronic phase. Patients previously treated for Chagas disease, pregnant women and
patients who declined to sign the informed consent were excluded. All subjects underwent
ECG and chest X-ray. Treatment with benznidazole was offered to all patients after the esoph-
ageal assessment.
A control group was selected from patients with heartburn who underwent an esophageal HRM
in our Hospital from April 2009 to April 2012. This control group was selected because heartburn
was the most frequent symptom among the CD cohort. Patients in the control group were born in
Spain (except for one patient that was from Equatorial Guinea) and had no risk factor for CD. All
patients in the control group were surveyed using the same questionnaire as the CD group.
Chagas disease diagnosis
Diagnosis of CD was based on two positive serological enzyme-linked immunosorbent assay
(ELISA) tests, one with recombinant antigen (Bioelisa Chagas, Biokit, Lliçà d’Amunt, Spain)
and the other with crude antigen (Ortho T. cruzi ELISA, Johnson & Johnson, High Wycombe,
United Kingdom). Additionally, T. cruzi DNA was assessed in the peripheral blood by qualita-
tive PCR before initiating treatment with benznidazole. PCR assay was performed according to
Piron et al[9].
Assessment of esophageal involvement
Rome III criteria were used to evaluate digestive symptoms through a personal interview. The
interviewer had a structured questionnaire to guide the process.[10] The following items were
included in the questionnaire: heartburn, dysphagia to liquids and solids, chest pain and
regurgitation.
All patients underwent barium esophagogram and high resolution manometry. Results of
the esophagograms were classified according to Rezende classification.[11]
High resolution manometry
All the manometric studies were carried out with HRM, consisting in a solid-state catheter
with 36 circumferential sensors, (each of them having 12 different entry ports), spaced by 1-cm
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distance along the intracorporal part of the catheter assembly (Sierra Scientific Instruments
Inc., Los Angeles, CA, USA). A fasting of a minimum of 8 hours was required before the proce-
dure. All the drugs that could interfere with the esophageal motility were discontinued. The
catheter was introduced transnasally with the patient seated, until the most distally recording
sensors were correctly placed in the stomach. Once positioned, the catheter was fixed in place
by taping it to the nose. Subsequently, the patient adopted the supine position and the begin-
ning of the protocol was postponed 1 minute approximately, to facilitate the relaxation and sta-
bilization of the esophageal motility. The protocol started with the measurements of the basal
sphincters’ pressure after a 30-second period. During this time, the patient was requested to
breathe normally and not swallow. A minimum of 10 swallows of water of 5-ml each were then
administered spaced by 30 seconds. As a supplemental test, a final multiple rapid swallowing
was performed in every patient previously to the catheter removal. Manometric data were ana-
lyzed using dedicated software, (ManoView, Given Imaging, Yoqneam, Israel), following the
indications reported by Pandolfino et al. [12] The esophagogastric junction (EGJ) was firstly
characterized. The proximal and distal limits were identified as abrupt increased changes in the
pressure relative to both the intraesophageal and the intragastric pressures. Once identified, the
integrated relaxation pressure (IRP) was recorded. An IRP equal or lower than 15 mmHg was
considered normal. The distal esophageal body contractions were analyzed by the generation
of isobaric contour plots at 30 mmHg. The mean values of the variables: Basal upper esoph-
ageal sphincter (UES) pressure (normal value 34–104 mmHg), relaxing UES pressure (normal
value<12 mmHg), contractile front velocity (CFV) (normal value<9.0 cm/s), distal contrac-
tile integrated (DCI) (normal range 450–8000 mmHg s cm) and distal latency (DL) (normal
value>4.5 seconds) were recorded in each study. [13]
The overall motility pattern was firstly classified following the 2012 Chicago classification
criteria and reviewed after the recent publication of the new guidelines. [14,15] Thereby, the
main categories considered were disorders with EGJ outflow obstruction (achalasia types I, II
and III and EGJ outflow obstruction), major disorders of peristalsis (distal esophageal spasm,
jackhammer esophagus, absent contractility), minor disorders of peristalsis (ineffective motility
and fragmented peristalsis) and normal esophageal motility.
Interobserver agreement
To avoid observer-dependent bias, all the HRM reports were analyzed by two experimented
gastroenterologists who were unaware of the symptoms of the patient. If any disagreement was
encountered, it was brought to discussion and the final decision was decided in consensus.
Statistical analysis
Data were analyzed with IBM SPSS Statistics software (v.21.0.0.0; IBM SPSS, Armonk, NY).
The median and interquartile range (IQR) were calculated for quantitative variables. Frequen-
cies and percentages were calculated for qualitative variables. Analysis was performed using
Student’s t-test or Mann–Whitney’s U test for quantitative variables and Chi-square test or
Fisher’s test for qualitative variables when appropriate. Tests were considered significant when
the two-tailed p-value was<0.05.
Ethical considerations
The study protocol was approved by the Ethical Review Board of Vall d’Hebron Hospital (Bar-
celona, Spain) and procedures were carried out in accordance with the ethical standards laid
down in the Helsinki Declaration as revised in 2000. All patients signed the informed consent
after a careful explanation of the study.
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Results
Initially, 73 patients with a confirmed diagnosis of CD were included in the study. Sixty two
patients fulfilled the study protocol and were analyzed. The remaining 11 patients did not
come to perform the HRM and declined to reschedule the test. Thirty patients were included in
the control group.
In the CD group, the median age was 37 (IQR 32–45) years. Forty two (67.7%) patients
were female. All the patients in the CD group were migrants from Latin American countries
(60 (96.8%) patients were from Bolivia, one from Paraguay and one from Equador). When
comparing baseline characteristic between the two groups, the control group was older (37 vs
51 years; p<0.001) and had more esophageal symptomatology (43.5% vs 93.3%; p<0.001) than
the CD group. More information is shown in Table 1.
The clinical questionnaire was carried out in all included patients. Almost half of the CD
group (27 patients (43.5%)) was symptomatic. From the symptomatic patients with CD, none
of them referred a disabling intensity in any of the symptoms. Overall, the most frequent symp-
tom was heartburn, which was referred by 19 (30.6%) patients. This was largely followed by
regurgitation and dysphagia to solids. Among patients in the control group, 28 (93.3%) patients
had at least one symptom and 6 (20%) patients referred disabling symptoms. Clinical data are
summarized in Table 1.
The esophagograms were performed in 57 patients (92% of the CD group) being normal in
the vast majority of the cases (52 patients (91.23%)). Only 5 (8.77%) patients had hiatus hernia.
The esophagogram assessment was not performed in the control group. Fig 1 shows examples
of HRM tracings.
A pathological motility pattern was seen in 14 (22.6%) patients in CD group. The HRM pat-
tern more frequently found was minor disorders of the peristalsis (13 with ineffective esoph-
ageal motility and 1 with fragmented peristalsis). Hypotonic LES was present in 13 patients in
the CD group, while in the control group 1 patient had hypotonic LES and 3 patients had
hypertonic LES (p = 0.005). UES was normal in 39 (62.9%) patients, hypertonic in 22 (35.5%)
and hypotonic in 1 patient in the CD group. In the control group 18 (60%) patients had a nor-
mal UES, 9 (30%) a hypertonic UES and 3 a hypotnic UES. More data can be found in Table 2
(HRM technical parameters) and in Table 3 (manometric patterns according to Chicago
classification).
Table 1. Epidemiological and clinical data.
Chagas group (n = 62) Heartburn control group (n = 30) P value
Sex, female 42 (67.7%) 23 (76.7%) 0.468
Age, years 37 (32–46) 51 (37–66) <0.001
Years living in host country 6 (5–8) NA
Bolivian origin 60 (96.8%) NA
Positive T cruzi PCR n = 58 28 (45.2%) NA
Normal esophagogram n = 57 52 (83.9%) NA
Symptoms
Heartburn 19 (30.6%) 28 (93.3%) <0.01
Dysphagia to liquids 4 (6.5%) 10 (33.3%) 0.02
Dysphagia to solids 9 (14.5%) 12 (40%) 0.009
Chest pain 3 (4.8%) 14 (46.7%) <0.001
Regurgitation 9 (14.5%) 17 (56.7%) <0.001
Any esophageal symptoms 27 (43.5%) 28 (93.3%) <0.001
Note: Data are reported as number (percentage) of patients and mean values (interquartile range).
doi:10.1371/journal.pntd.0004416.t001
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When comparing manometric parameters or patterns in the CD group according to any
esophageal symptom no statistically significant association was seen, except for the median val-
ues in the DL parameter (7.2 symptomatic patients vs 6.5 non-symptomatic patients;
p = 0.049), however all the patients were considered to have normal values. Data are depicted
in Table 4.
Discussion
Our study describes the main esophageal HRM findings in a cohort of consecutive patients
with chronic CD. It reports the presence of low-intensity esophageal symptoms in almost half
of the patients in the CD group, but there was no association between esophageal symptoms
and the findings in the esophageal HRM.
In CD the esophageal involvement is mainly characterized by the loss of the myenteric
plexus. This translates in a motility pattern similar to that described in idiopathic achalasia,
consisting in simultaneous contractions of low amplitude in the esophageal body, however LES
in CD patients with esophageal involvement tends to be normal or hypotonic.[16,17] These
alterations have been thoroughly studied with conventional esophageal manometry, however,
few studies to date have reported the main pathological findings using HRM.
Fig 1. Examples of the high-resolution manometric studies in patients with Chagas disease: (A) Normal lower esophageal sphincter pressure and
esophageal peristalsis (B) Hypotonic LES and normal peristalsis and (C) Ineffective esophageal motility and hypotonic LES. LES: lower esophageal
sphincter.
doi:10.1371/journal.pntd.0004416.g001
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Herein, no specific inclusion criteria regarding the symptoms were applied to avoid selec-
tion bias, and therefore, obtain a representative sample of the chronic CD population. Thus,
56.5% of the cohort was completely asymptomatic. This percentage is consequent with current
literature findings, reporting values that range between 33–52%.[18,19] These percentages can-
not be interpreted as a lack of esophageal involvement due to CD as it has been described that
symptoms do not arise until the neuronal damage is extensive, [20] and as our study shows the
vast majority of the patients had a normal esophageal HRM despite low esophageal symptoms.
The first symptom usually developed in the course of esophageal involvement in patients
with CD is dysphagia, however depending on the study the results may vary. [7] In our study,
Table 2. Technical manometric parameters according to study group.
Chagas group (n = 62) Heartburn control group (n = 30) P value
Basal LES pressure (mmHg) 7.2 (5–11.93) 14.65 (10.2–20.9) <0.001
Status Basal LES 0.005
Normal Basal LES pressure 49 (79%) 26 (86.7%)
Hypotonic Basal LES pressure 13 (21%) 1 (3.3%)
Hypertonic Basal LES pressure 0 3 (10%)
IRP (mmHg) 5.5 (51.75–77.75) 8.65 (5.03–10) 0.115
Normal IRP N: (<15mmHg) 62 (100%) 29 (96.7%) 0.326
CFV (cm/s) 3.1 (2.58–3.53) 3.6 (2.7–4.55) 0.071
Normal CFV (N: <9cm/S) 62 (100%) 28 (96.7%) 0.326
DCI (mmHg s cm) 978.25 (741.03–1657.58) 1279 (835.4–2199.35) 0.014
Normal DCI (N: 450–8000 mmHg s cm) 58 (93.5%) 28 (96.6%) 1
DL (seconds) 7 (6.28–7.63) 6.6 (5.6–7.2) 0.15
Normal DL (N: >4.5s) 62 (100%) 29 (100%) NA
IBP (mmHg) 0.9 (-0.53–3.03) 21.1 (16.9–25.2) <0.001
Basal UES pressure (mmHg) 86.75 (64.65-135-23) 74 (51.1–115.43) 0.078
Normal basal pressure UES (N: 34–104mmHg) 39 (62.9%) 18 (60%) 0.788
Relaxing UES pressure (mmHg) 3.75 (1.08–8.05) 6.15 (3.18–9.83) 0.011
Normal Relaxing pressure UES (N: <12mmHg) 58 (93.5%) 24 (80%) 0.073
Note: LES, lower esophageal sphincter; IRP, Integrated relaxation pressure; CFV, contractile front velocity; DCI, distal contractile integral; DL, distal
latency; IBP, Intrabolus pressure; UES, upper esophageal sphincter. Data are reported as number (percentages) of patients and mean values
(interquartile range).
doi:10.1371/journal.pntd.0004416.t002
Table 3. High resolution manometries results according to the Chicago classification in Chagas cohort and control group.
Classification Chagas group (n = 62) Control group (n = 30) P value
Normal 48 (77.4%) 24 (80%) 0.776
Achalasia or EGJ outflow obstruction 0 0 NA
Major disorders of peristalsis 0 2 (6.7%) .104
Absent contractility 0 0
Distal esophageal spasm 0 1 (3.35%)
Hypercontractile esophagus 0 1 (3.35%)
Minor disorders of peristalsis 14 (22.6%) 4 (13.3%) 0.295
Ineffective esophageal motility 13 (21%) 4 (13.3%)
Fragmented peristalsis 1 (1.6%) 0
Note: Data are reported as number (percentages) of patients.
doi:10.1371/journal.pntd.0004416.t003
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the most frequent symptom was heartburn, while dysphagia was present only in few patients.
Heartburn in patients with CD is frequently accompanied by normal esophageal tests, while
dysphagia goes normally with altered esophageal tests. Heartburn is a very common symptom
in the community and its positive predictive value for esophageal involvement in patients with
CD is low. This observation may be explained by the low esophageal involvement in our cohort
and goes accordingly with previous studies. [18,21] When great damage is already established
in the esophagus, heartburn gives way to dysphagia as the main symptom.
On the other hand, it should be mentioned that 10 patients of our study referred dysphagia
(3 of them with dysphagia to both solid and liquids). In 9 of these cases, the barium esophago-
gram was strictly normal, (one patient did not have this test performed), and in 8 patients the
HRM was informed as completely normal. The remaining 2 had minor disorders of the peri-
stalsis which may be considered an early manifestation of CD esophageal involvement. Hence,
it seems possible that dysphagia in these patients was not a consequence of CD as this symptom
appears once there is a large damage of the esophagus.
The results of the diagnostic tests were also remarkable for the absence of significant patho-
logical findings. None of the barium esophagograms showed any grade of dilatation, with the
only abnormality being a hiatus hernia. Based on our findings, we suggest that barium esopha-
gograms should not be performed as part of the initial evaluation of every patient with chronic
CD, due to its lack of discrimination of early esophageal alterations.
HRM provides clear advantages with respect of conventional manometry in the characteriza-
tion of the esophageal contractions and, more importantly, in the definition and features of the
LES. [22] As a result, it has been postulated that the application of this technique in the evalua-
tion of chronic CD would lead into the description of motility patterns that may have been unno-
ticed with conventional manometry. Surprisingly, in our cohort the motility alterations were
remarkably mild. For instance, 77.4% of the sample had a complete normal HRM report. In the
remaining patients, 14 patients had minor disorders of the peristalsis. When comparing with the
Table 4. Relationship between the manometric findings and the symptoms in patients with Chagas disease.
Absence of symptoms (n = 31) Presence of the symptoms (N = 27) P value
Normal HRM 23 (74.2%) 23 (85.2%) 0.303
Basal LES pressure (mmHg) 6.4 (4.2–11.5) 8 (5.2–13.2) 0.627
Normal Basal LES pressure 24 (77.4%) 22 (81.5%) 0.703
IRP (mmHg) 5.4 (3.4–9.5) 5.4 (4.2–7.7) 0.899
Normal IRP N: (<15mmHg) 31 (100%) 27 (100%) NA
CFV (cm/s) 3.2 (2.4–3.6) 3.2 (2.8–3.7) 0.973
Normal CFV (N: <9cm/S) 31 (100%) 27 (100%) NA
DCI (mmHg s cm) 1107.4 (769.2–1817.9) 899.4 (542.3–1557.7) 0.264
Normal DCI (N: 450–8000 mmHg s cm) 28 (90.3%) 26 (96.3%) 0.615
DL (seconds) 7.2 (6.4–7.7) 6.5 (5.9–7.3) 0.049
Normal DL (N: >4.5s) 31 (100%) 27 (100%) NA
Basal UES pressure (mmHg) 98.5 (70–140) 83.1 (61.7–134.3) 0.271
Normal basal pressure UES (N: 34–104mmHg) 17 (54.8%) 19 (70.4) 0.224
Relaxing UES pressure (mmHg) 4 (1–8.9) 3 (1.6–7) 0.697
Normal Relaxing pressure UES (N: <12mmHg) 30 (96.8%) 25 (92.6%) 0.593
Note: HRM, high resolution manometry; LES, lower esophageal sphincter; IRP, Integrated relaxation pressure; CFV, contractile front velocity; DCI, distal
contractile integral; DL, distal latency; IBP, Intrabolus pressure; UES, upper esophageal sphincter. Data are reported as number (percentages) of patients
and mean values (interquartile range).
doi:10.1371/journal.pntd.0004416.t004
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heartburn control group, the basal pressure of the LES was lower in the CD group and the rate of
hypotonic LES was also statistically lower. These findings are in concordance with current knowl-
edge that states that the involvement of the esophagus of CD is due to destruction of the enteric
nervous system, affecting both inhibitory and excitatory nerves [6].
There are four studies that assessed esophageal HRM in patients with chronic CD. All of them
were performed in endemic countries. Two studies performed by Vicentine et al [23,24] in Brazil
included patients with CD and dilatation of the esophagus and one study by Silva et al [25] also
performed in Brazil selected patients with symptoms. These three studies cannot be compared
with our study because their cohorts were selected among symptomatic patients or patients with
achalasia-like esophagus. The remaining study by Remes-Troche et al [18] included 42 consecu-
tive patients irrespective of their clinical symptoms. They found symptoms in 33% of the patients.
The HRM assessment surprisingly showed that 28 (66%) of the patients had esophageal motility
disorders according to the former Chicago classification. However, with the new Chicago classifi-
cation it is probable that less esophageal abnormality would have been described. Our study also
found that the most frequent abnormality is minor disorders of the peristalsis, however we did
not find any patients with major disorders, EGJ outflow obstruction or achalasia. On the other
hand, no statistically significant relationship was seen between the presence or absence of symp-
toms and the esophageal HRM findings in our cohort, similarly to previous studies. [21]
We acknowledge some limitations in our study. The limited sample size may have prevented
us to find some significant associations between the symptoms and the manometric findings
due to a possible lack of power. Moreover, a specific study with upper endoscopy or pH-metry
was not performed as part of the study protocol to further characterize the heartburn referred
by some of the patients. Additionally, the control group was not matched to the cohort with
respect to origin and age, so some findings may be attributed to these factors.
To the best of our knowledge, this is one of the few studies to date using esophageal HRM in
chronic CD and the first reporting this technique in a non-endemic country. We reported
esophageal motility disorder in 22.6% of a cohort of consecutive CD patients. Symptoms and
esophagogram results did not matched with the HRM results. We believe that further prospec-
tive studies are needed, especially with HRM, to elucidate the evolution of early abnormal
motility patterns in chronic esophageal CD.
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